Eli Lilly Wins First Approval in China for Oral GLP-1 Weight-Loss Pill

China approved Eli Lilly’s orforglipron pill for weight loss, giving it an early lead over Novo Nordisk in the world’s second-largest drug market.

Eli Lilly Wins First Approval in China for Oral GLP-1 Weight-Loss Pill
Credit: Bloomberg
Already have an account? Sign in.